Scientists at Scripps Institution of Oceanography at UC San Diego have developed a new genetic platform that allows efficient production of naturally occurring molecules, and have used it to produce a novel antibiotic compound. Their study, published this week in Proceedings of the National Academy of Sciences, may open new avenues for natural product discoveries and drug development.
According to lead investigator Bradley Moore of Scripps Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences at UC San Diego, the findings demonstrate a “plug and play” technique to trigger previously unknown biosynthetic pathways and identify natural product drug candidates.
“In my opinion, the new synthetic biology technology we developed—which resulted in the discovery of a new antibiotic from a marine bacterium—is just the tip of the iceberg in terms of our ability to modernize the natural product drug discovery platform,” Moore said.
The ocean, covering 70 percent of the earth’s surface, is a rich source of new microbial diversity for the discovery of new natural products effective as drugs for treating infections, cancer, and other important medical conditions. Most natural antibiotics are complex molecules that are assembled by a special group of enzymes genetically encoded in the microbe’s chromosome.
But it often proves difficult to grow the newly discovered ocean bacteria in the laboratory, or to get them to produce their full repertoire of natural products.
The UC San Diego scientists harvested a set of genes predicted to encode a natural product from ocean bacteria, then used the synthetic biology technology to identify and test a totally new antibiotic—called taromycin A—that has been found to be effective in fighting drug-resistant MRSA (methicillin-resistant Staphylococcus aureus).
“Antibiotic resistance is a critical challenge to public health. Most antibiotics, such as penicillin, used in human medicine are natural molecules originally isolated from microbes in the soil or rainforest—part of the chemical warfare that microbes deploy to out-compete one another and secure their niche in the environment,” said co-investigator Victor Nizet, MD, professor of pediatrics and pharmacy at UC San Diego.
Such microbes have the genetic capacity to biosynthesize a wide range of specialized compounds. Although next-generation sequencing technologies can potentially exploit this capacity as an approach to natural drug discovery, researchers currently lack procedures to efficiently link genes with specific molecules. To help bridge this gap, the UC San Diego researchers developed a genetic platform based on transformation-associated recombination (TAR) cloning, which efficiently produces natural product molecules from uncharacterized gene collections.
The researchers applied the platform to yeast, targeting the taromycin gene cluster because of its high degree of similarity to the biosynthesis pathway of daptomycin, a clinically approved antibiotic used to treat infections caused by multi-resistant bacteria.
“The technique has the potential to unlock the drug discovery potential of countless new and mysterious microbes,” Nizet concluded.
Additional contributors to the study include Kazuya Yamanaka, Kirk Reynolds, Roland Kersten, Katherine Ryan, David Gonzalez, and Pieter Dorrestein.
The study was supported by grants from the National Institutes of Health.
UC San Diego’s Technology Transfer Office has filed patent applications on this process and on the taromycin antibiotics, which are available for licensing. Visit invent.ucsd.edu for more information.
— Debra Kain
Scripps Institution of Oceanography at the University of California, San Diego, is one of the oldest, largest, and most important centers for global science research and education in the world. Now in its second century of discovery, the scientific scope of the institution has grown to include biological, physical, chemical, geological, geophysical, and atmospheric studies of the earth as a system. Hundreds of research programs covering a wide range of scientific areas are under way today on every continent and in every ocean. The institution has a staff of more than 1,400 and annual expenditures of approximately $195 million from federal, state, and private sources. Scripps operates robotic networks and one of the largest U.S. academic fleets. Birch Aquarium at Scripps serves as the interpretive center of the institution and showcases Scripps research and a diverse array of marine life through exhibits and programming for more than 430,000 visitors each year. Learn more at scripps.ucsd.edu.
About UC San Diego
The University of California, San Diego is a student-centered, research-focused, service-oriented public institution that provides opportunity for all. Recognized as one of the top 15 research universities worldwide and born of a culture of collaboration, UC San Diego sparks discoveries that advance society, drive economic growth and positively impact the world. Our students, who learn from Nobel laureates, MacArthur Fellows and National Academy members, are committed to public service. For the sixth consecutive year, UC San Diego has been ranked first in the nation based on research, civic engagement and social mobility. We are one campus with multiple pillars of excellence, a top ten public university that is transforming lives, shaping new disciplines and advancing the frontiers of knowledge. Learn more at www.ucsd.edu.